We are live on ! Find out more
CLYM

Climb Bio
CLYM

69 hedge funds and large institutions have $61.9M invested in Climb Bio in 2025 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% less capital invested

Capital invested by funds: $63.4M → $61.9M (-$1.5M)

3.13% less ownership

Funds ownership: 76.97% → 73.83% (-3.1%)

9% less funds holding

Funds holding: 76 → 69 (-7)

17% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 23

27% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 26

Holders
69
Holders Change
-7
Holders Change %
-9.21%
% of All Funds
0.91%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
19
Reduced
23
Closed
26
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CF
Cantor Fitzgerald
New York
+$626K
2
Alyeska Investment Group
Alyeska Investment Group
Illinois
+$604K
3
NFT
Nan Fung Trinity
Hong Kong
+$577K
4
Millennium Management
Millennium Management
New York
+$519K
5
SC
Shay Capital
New York
+$268K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.77M
2
NFGH
Nan Fung Group Holdings
Hong Kong
-$566K
3
SSA
Schonfeld Strategic Advisors
New York
-$540K
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$451K
5
State Street
State Street
Massachusetts
-$343K
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
76
Bank of New York Mellon
New York
– -$79.2K -64,914 Closed
BFM
77
Boothbay Fund Management
New York
– -$65.5K -53,662 Closed
N
78
Nuveen
North Carolina
– -$47.6K -39,034 Closed
XT
79
XTX Topco
Cayman Islands
– -$33.7K -27,660 Closed
RhumbLine Advisers
80
RhumbLine Advisers
Massachusetts
– -$30.2K -24,782 Closed
IIM
81
INTECH Investment Management
Florida
– -$25.6K -21,022 Closed
Mirae Asset Global ETFs Holdings
82
Mirae Asset Global ETFs Holdings
Hong Kong
– -$21.5K -17,618 Closed
Mariner
83
Mariner
Kansas
– -$21K -17,187 Closed
VPIM
84
Vanguard Personalized Indexing Management
California
– -$18.6K -15,225 Closed
CF
85
Corebridge Financial
Texas
– -$17.6K -14,416 Closed
New York State Common Retirement Fund
86
New York State Common Retirement Fund
New York
– -$12.8K -10,500 Closed
PFSRSONJ
87
Police & Firemen's Retirement System of New Jersey
New Jersey
– -$7.16K -5,869 Closed
SO
88
STRS Ohio
Ohio
– -$6.47K -5,300 Closed
AIP
89
Ameritas Investment Partners
Nebraska
– -$3.64K -2,981 Closed
Legal & General Group
90
Legal & General Group
United Kingdom
– -$3.16K -2,581 Closed
California State Teachers Retirement System (CalSTRS)
91
California State Teachers Retirement System (CalSTRS)
California
– -$2.65K -2,169 Closed
MCP
92
Militia Capital Partners
Nevada
– -$2.07K -1,700 Closed
AB
93
Amalgamated Bank
New York
– -$1K -1,016 Closed
SCM
94
Sterling Capital Management
North Carolina
– -$584 -479 Closed
CCM
95
Coldstream Capital Management
Washington
– -$410 -336 Closed
1 2 3
4

CLYM Hedge Fund Activity: Q2 2025 in Review

69 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Climb Bio (CLYM) for Q2 2025, worth a combined $61.9M — down 2.4% from $63.4M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of CLYM and 19 opened new positions — a net loss of 7 holders — while 23 trimmed existing stakes and 19 added.

The largest buyer was Cantor Fitzgerald, adding an estimated $626K. The largest seller was BlackRock, cutting an estimated $1.77M.

  • 69 institutional investors held Climb Bio (CLYM) as of Q2 2025, down from 76 in Q1 2025.
  • Funds reported $61.9M of Climb Bio stock for Q2 2025, down 2.4% quarter-over-quarter.
  • 19 funds opened new Climb Bio positions in Q2 2025 and 26 closed out, a net change of -7 holders.
  • The largest Climb Bio buyer in Q2 2025 was Cantor Fitzgerald, an estimated $626K added.
  • The largest Climb Bio seller in Q2 2025 was BlackRock, an estimated $1.77M sold.

Based on aggregated 13F filings for Q2 2025.